TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Sanofi-Aventis Norge AS
Closing information (x1000 NOK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
843,258
|
751,239
|
689,984 |
| Financial expenses |
4,731
|
1,304
|
1,309 |
| Earnings before taxes |
48,730
|
41,999
|
59,552 |
| Total assets |
359,000
|
351,862
|
398,813 |
| Current assets |
355,742
|
349,308
|
396,264 |
| Current liabilities |
344,119
|
346,589
|
347,867 |
| Equity capital |
14,881
|
5,273
|
50,946 |
| - share capital |
1,820
|
1,820
|
1,820 |
| Employees (average) | 64 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
4.1%
|
1.5%
|
12.8% |
| Turnover per employee | 13,176 | ||
| Profit as a percentage of turnover |
5.8%
|
5.6%
|
8.6% |
| Return on assets (ROA) |
14.9%
|
12.3%
|
15.3% |
| Current ratio |
103.4%
|
100.8%
|
113.9% |
| Return on equity (ROE) |
327.5%
|
796.5%
|
116.9% |
| Change turnover |
92,019
|
61,255
|
-44,637 |
| Change turnover % |
12%
|
9%
|
-6% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.